TMDX (TransMedics) יחס שווי שוק לשווי בספרים

TransMedics Group (TMDX) leads the organ preservation sector, leveraging exclusive aviation logistics and unique organ preservation methods to secure a monopoly position. This daily price chart clearly demonstrates the company's market position, where the indicator stands at 4.76. Business growth is driven by the implementation of the OCS system, an increase in the number of heart and liver transplant operations, and the scaling of its own aircraft fleet.

This indicator compares the current market value of TransMedics Group (TMDX) to its net assets, allowing a conservative investor to identify business overvaluation through the historical market-to-book ratio. The high premium to book value is justified here by the unique human capital of bioengineers, whose life-saving mission creates intangible value that exceeds the company's formal accounting metrics.